// App-Quantinova.ai

PO‐071 : Hands‐on district general hospital experience of rituximab‐idelalisib in a co‐morbid elderly cohort with chronic lymphocytic leukaemia

Researchers

Presenter

  • R Ayto

Principal Investigators

  • J Anupama

  • V Ragoonanan

  • S Arami

  • M Heath

Medical Centers

  • Gastroenterology, Northwick Park Hospital, Middlesex, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Bone Morphogenetic Protein 1

  • Tumor protein p53

Drug/Treatment

  • Bendamustine

  • chlorambucil

  • Prednisolone

  • Alemtuzumab

  • fludarabine tablet

  • Idelalisib

  • Venetoclax

  • Ibrutinib

  • Rituximab

  • TP53

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved